This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Breast imaging organizations and political bodies are criticizing updated guidelines on breast cancer screening by the Canadian Task Force on Preventive Health Care (CTFPHC). Released on May 30 , the task force’s draft guidelines recommend that women between the ages of 40 and 49 should not be systematically screened. Instead, these women are advised to have informed conversations with their primary care provider and make their own screening decisions from there.
“This result indicates a significant shift in public perception and trust toward technology,” according to new survey data from consumer research firm Innerbody.
PET imaging with nitrogen-13 (N-13) ammonia radiotracer can help predict major adverse cardiac events in patients with ischemic heart disease (IHD), according to a study published May 30 in Radiology: Cardiothoracic Imaging. A group at Kyushu University in Fukuoka, Japan, found that right ventricular myocardial strain ratio (RVMSR) measurements on N-13 ammonia PET images predicted cardiovascular events and suggested the approach can be used to identify patients who would benefit from clinical in
Although DBT exams are proven to identify more difficult to detect cancers, especially among women with dense breasts, they also include significantly more images than standard 2D mammograms.
Amidst rising cancer prevalence and soaring costs, new cancer technologies and innovations are emerging to support the early detection, treatment, and surveillance of cancer. Read this guide to understand how to evaluate these solutions for your employees and members – and to learn more about the current state of coverage, clinical and cost effectiveness, and impact on quality and outcomes.
The state of Washington is reducing barriers to certifying new radiologic technologists, especially MRI providers, with a new workforce bill that goes into effect June 6. HB 2355 relates to establishing a primary certification process for MRI technologists. Before the bill, MRI technologist was not one of the titles among certified radiologic technologists in Washington.
It may just be the marketing, but the newly announced DC-1 tablet from Daylight seems poised to scratch an itch of our times. As summarized by Om Malik : What the company has created is a beautiful tablet — about the size of a normal iPad Air. It is just a “little less than white,” white, with a gorgeous screen. It is very simple, elegant, and lovely.
It may just be the marketing, but the newly announced DC-1 tablet from Daylight seems poised to scratch an itch of our times. As summarized by Om Malik : What the company has created is a beautiful tablet — about the size of a normal iPad Air. It is just a “little less than white,” white, with a gorgeous screen. It is very simple, elegant, and lovely.
The U.S. Food and Drug Administration (FDA) has cleared CARPL.ai 's web-based PACS and radiology workflow management device. The approval of the enterprise imaging AI platform "opens the door for widespread adoption of AI solutions through a platform approach," said CARPL.ai CEO Vidur Mahajan. CARPL's system offers radiologists and other physicians a simplified process for selecting, implementing, and procuring third-party AI models that have been cleared by the FDA.
MRI scans are commonly used to diagnose a variety of conditions, anything from liver disease to brain tumors. But, as anyone who has been through one knows, patients must remain completely still to avoid blurring the images and requiring a new scan. A prototype device described in ACS Sensors could change that. The self-powered sensor detects movement and shuts down an MRI scan in real time, improving the process for patients and technicians.
ConcertAI will spotlight its new and expanded multimodal and real-world data management offerings with Cara AI and the TeraRecon Oncology Suite at the American Society of Clinical Oncology (ASCO)'s annual meeting this week. Both products are designed to enhance research capabilities and support complex clinical study workflows, according to ConcertAI.
Current research indicates that robotic ultrasound systems capable of conducting routine examinations autonomously and assisting doctors in the operating theater.
Patient-centric scheduling can only be achieved through optimized radiology workflows, effective communications between staff and physicians, and, of course, through specialized schedulers. In this guide, we’ll take you through a step-by-step process to transform your radiology center into a high-performance hub of medical imaging.
A convolutional neural network successfully flagged 95% of breast cancer patients with axillary metastasis, demonstrating potential to reduce unnecessary biopsies.
Additional carcinoma in the ipsilateral breast was detected on preoperative MRI exams in 24 out of 102 women prior to lumpectomy and mastectomy procedures, according to new study findings presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.
MRI scans are commonly used to diagnose a variety of conditions, anything from liver disease to brain tumors. But, as anyone who has been through one knows, patients must remain completely still to avoid blurring the images and requiring a new scan. A prototype device could change that. The self-powered sensor detects movement and shuts down an MRI scan in real time, improving the process for patients and technicians.
Leaders in the insurance industry are still facing lingering challenges around remote and hybrid work, as well as pushback on return-to-office plans. They’re making an effort to focus on the employee experience, professional development and innovative talent strategies as they plan for success in the evolving business climate. They are striving to reach a balance that meets organizational needs while also respecting individuals’ priorities.
About 40% of us will be diagnosed with cancer in our lifetime, and patients are getting younger. At the same time, the cost of treatment continues to rise, with employers spending 8.5% more on cancer care for each employee than they did last year. The best thing employers can do for their employees and business tomorrow is to invest in cancer detection and care today.
As women, we juggle careers, family, and a myriad of daily responsibilities, often putting our own needs last. However, taking time for self-care is crucial, especially when it comes to our health. One vital practice is performing regular self-breast exams (SBEs). This simple yet effective habit can be a game-changer in the early detection of breast cancer.
The AI-powered Heuron ICH software reportedly has an 86 percent sensitivity rate for diagnosing intracranial hemorrhage on computed tomography (CT) scans.
Publication date: Available online 31 May 2024 Source: Clinical Radiology Author(s): Susan Cheng Shelmerdine, Daniel Togher, Simon Rickaby, Geraldine Dean
Discover how Color's comprehensive care solution is revolutionizing cancer screening adherence and knowledge. Through an in-depth case study, Color's unique approach to comprehensive cancer care has shown significant benefits in increasing screening rates and enhancing patient knowledge. Participants reported a 2-3x increase in adherence to screening guidelines over just 8 weeks, with 84% of participants increasing their familiarity with timing and frequency of cancer screening.
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
290 
Let's personalize your content